On 17 May, the European Commission may well indeed put its proposal on endocrine disruptors to a vote. The compromise to be presented to national experts that day authorised intended disruptors but withdraws the idea of a derogation for active substances that present a negligible risk.
It should be pointed out that in the middle of last year, the Commission proposed retaining three criteria for identifying (and ultimately banning) chemical substances that dangerously interfere with the...